Skip to main content
SpringerLink
Log in

Lacticaseibacillus paracasei K56 Attenuates High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota in Mice

  • Published:
Probiotics and Antimicrobial Proteins Aims and scope Submit manuscript

Abstract

This study investigated the effects of Lacticaseibacillus paracasei K56 (L. paracasei K56) on body weight, body composition, and glycolipid metabolism in mice with high-fat diet-induced obesity and explored the underlying mechanisms. Male C57BL/6J mice were fed a high-fat diet for 8 weeks to induce obesity; then, the obese mice were gavaged with or without L. paracasei K56 for 10 weeks. The body weight, body composition, fat mass, blood lipid, blood glucose, and hormones of the mice were evaluated. Moreover, the fatty acid synthesis (FAS) and peroxisome proliferator-activated receptor γ (PPAR-γ) expressions in the liver were detected via Western blotting. 16S rRNA gene sequencing was adopted to determine the gut microbiota alterations. The high-fat diet successfully induced obesity, as indicated by the abnormal increase in body weight, visceral fat, fat mass, blood lipids, fasting blood glucose, and insulin-resistance. Moreover, the FAS expression in the liver was significantly increased, whereas the PPAR-γ expression was significantly decreased. The relative abundance of Proteobacteria, Actinobacteria and Patescibacteria was also significantly increased, and that of Verrucomicrobia was significantly decreased. However, these indicators of mice supplemented with L. paracasei K56 were significantly opposite to those of obese mice. The Ruminococcuaceae_UCG-013, Akkermansia, Prevotellaceae_UCG-001, Muribaculum, and Lachnospiraceae_NK4A136 groups were significantly negatively correlated with body weight, blood lipids, and blood glucose-related indicators, whereas Coriobacteriaceae_UCG-002, Enterorhabdus, Raoultibacter, Acinetobacter, Romboutsia, Leuconostoc, and Erysipelatoclostridium were significantly positively correlated with these indicators. L. paracasei K56 might be a promising probiotic strain that could effectively slow down the body weight gain, reduce fat accumulation, alleviate insulin-resistance, and restore pancreatic β-cell function in obese mice by regulating the gut microbiota.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

All data included in this study are available upon request by contact with the corresponding author. Raw reads of 16S rRNA sequencing data is submitted to Sequence Read Archive (SRA) under the BioProject ID PRJNA722791 in NCBI.

References

  1. GBD 2015 Obesity Collaborators (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27. https://doi.org/10.1056/NEJMoa1614362

    Article  Google Scholar 

  2. Blüher M (2019) Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 15(5):288–298. https://doi.org/10.1038/s41574-019-0176-8

    Article  PubMed  Google Scholar 

  3. Rothschild D, Weissbrod O, Barkan E et al (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555(7695):210–215. https://doi.org/10.1038/nature25973

    Article  CAS  PubMed  Google Scholar 

  4. Gomes AC, Hoffmann C, Mota JF (2018) The human gut microbiota: metabolism and perspective in obesity. Gut Microbes 9(4):308–325. https://doi.org/10.1080/19490976.2018.1465157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Green M, Arora K, Prakash S (2020) Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome. Int J Mol Sci 21(8). https://doi.org/10.3390/ijms21082890

  6. Castaneda-Marquez AC, Diaz-Benitez C, Bahena-Roman M et al (2020) Lactobacillus paracasei as a protective factor of obesity induced by an unhealthy diet in children. Obes Res Clin Pract 14(3):271–278. https://doi.org/10.1016/j.orcp.2020.04.005

    Article  PubMed  Google Scholar 

  7. Cheng MC, Tsai TY, Pan TM (2015) Anti-obesity activity of the water extract of Lactobacillus paracasei subsp. paracasei NTU 101 fermented soy milk products. Food Funct 6(11):3522–3530. https://doi.org/10.1039/c5fo00531k

  8. Tanida M, Shen J, Maeda K et al (2008) High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes Res Clin Pract 2(3):159–169. https://doi.org/10.1016/j.orcp.2008.04.003

    Article  Google Scholar 

  9. Cui XW, Shi YY, Gao SY et al (2019) Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study. Ital J Pediatr 45(1):140. https://doi.org/10.1186/s13052-019-0716-9

  10. Lai HH, Chiu CH, Kong MS et al (2019) Probiotic Lactobacillus casei: effective for managing childhood diarrhea by altering gut microbiota and attenuating fecal inflammatory markers. Nutrients 11(5):1150. https://doi.org/10.3390/nu11051150

  11. Cheng RY, Guo JW, Pu FF et al (2019) Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood. Sci Rep 9(1):3254. https://doi.org/10.1038/s41598-018-35737-1

  12. Meng L, Duan S, Situ W et al (2020) Probiotic edible composition useful in preparing food for promoting digestive function, comprises Bifidobacterium lactis BL-99, Lactobacillus paracasei K56 and Lactobacillus paracasei ET-2. In.: Inner Mongolia Yili Ind Group Co Ltd. Patent Number: CN110903995-A

  13. Min QQ, Sun T, Xu JY et al (2021) Differential modulation of the metabolic effects of diet-induced obesity by probiotic Lactobacillus Paracasei K56 and prebiotic alpha-galactooligosaccharides. Curr Top Nutraceutical Res 19(1):21–28. https://doi.org/10.37290/ctnr2641-452X.19:21-28

  14. Jayashree B, Bibin YS, Prabhu D et al (2014) Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 388(1–2):203–210. https://doi.org/10.1007/s11010-013-1911-4

    Article  CAS  PubMed  Google Scholar 

  15. Mulders RJ, de Git KCG, Schele E et al (2018) Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes Rev 19(4):435–451. https://doi.org/10.1111/obr.12661

    Article  CAS  PubMed  Google Scholar 

  16. Zhao D, Zhu H, Gao F et al (2020) Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice. Food Funct 11(7):6528–6541. https://doi.org/10.1039/d0fo00180e

    Article  CAS  PubMed  Google Scholar 

  17. Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031. https://doi.org/10.1038/nature05414

    Article  PubMed  Google Scholar 

  18. Ranganathan G, Unal R, Pokrovskaya I et al (2006) The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47(11):2444–2450. https://doi.org/10.1194/jlr.M600248-JLR200

    Article  CAS  PubMed  Google Scholar 

  19. Janani C, Ranjitha Kumari BD (2015) PPAR gamma gene–a review. Diabetes Metab Syndr 9(1):46–50. https://doi.org/10.1016/j.dsx.2014.09.015

    Article  CAS  PubMed  Google Scholar 

  20. Chang CJ, Lin CS, Lu CC et al (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489. https://doi.org/10.1038/ncomms8489

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhang T, Li QQ, Cheng L et al (2019) Akkermansia muciniphila is a promising probiotic. Microb Biotechnol 12(6):1109–1125. https://doi.org/10.1111/1751-7915.13410

    Article  PubMed  PubMed Central  Google Scholar 

  22. Massier L, Chakaroun R, Tabei S et al (2020) Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes. Gut 69(10):1796–1806. https://doi.org/10.1136/gutjnl-2019-320118

    Article  CAS  PubMed  Google Scholar 

  23. Amorim AM, Nascimento JD (2017) Acinetobacter: an underrated foodborne pathogen?. J Infect Dev Countr 11(2):111–114. https://doi.org/10.3855/jidc.8418

    Article  CAS  Google Scholar 

  24. Zhou HX, Tai JJ, Xu HY et al (2019) Xanthoceraside could ameliorate Alzheimer’s disease symptoms of rats by affecting the gut microbiota composition and modulating the endogenous metabolite levels. Front Pharmacol 10:1035. https://doi.org/10.3389/fphar.2019.01035

  25. Mu HN, Zhou Q, Yang RY et al (2020) Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice. Front Microbiol 11:585066. https://doi.org/10.3389/fmicb.2020.585066

  26. Lee CJ, Sears CL, Maruthur N (2020) Gut microbiome and its role in obesity and insulin resistance. Ann Ny Acad Sci 1461(1):37–52. https://doi.org/10.1111/nyas.14107

    Article  PubMed  Google Scholar 

  27. Milosevic I, Vujovic A, Barac A et al (2019) Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci 20(2). https://doi.org/10.3390/ijms20020395

  28. Zhou JC, Zhang XW (2019) Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases. Chin J Nat Medicines 17:835–841. https://doi.org/10.1016/S1875-5364(19)30101-3

    Article  CAS  Google Scholar 

  29. Song XF, Zhong L, Lyu N et al (2019) Inulin can alleviate metabolism disorders in ob/ob mice by partially restoring leptin-related pathways mediated by gut microbiota. Genom Proteom Bioinf 17(1):64–75. https://doi.org/10.1016/j.gpb.2019.03.001

    Article  CAS  Google Scholar 

  30. Koh A, De Vadder F, Kovatcheva-Datchary P et al (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

    Article  CAS  PubMed  Google Scholar 

  31. Sinha SR, Haileselassie Y, Nguyen LP et al (2020) Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27(4):659-670.e655. https://doi.org/10.1016/j.chom.2020.01.021

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Liang HJ, Jiang FL, Cheng RY et al (2021) A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice. Exp Anim 70(1):73–83. https://doi.org/10.1538/expanim.20-0094

    Article  CAS  PubMed  Google Scholar 

  33. Vallim TQD, Tarling EJ, Edwards PA (2013) Pleiotropic roles of bile acids in metabolism. Cell Metab 17(5):657–669. https://doi.org/10.1016/j.cmet.2013.03.013

    Article  CAS  Google Scholar 

  34. He B, Moreau R (2019) Lipid-regulating properties of butyric acid and 4-phenylbutyric acid: molecular mechanisms and therapeutic applications. Pharmacol Res 144:116–131. https://doi.org/10.1016/j.phrs.2019.04.002

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank GENE DENOVO for providing assistance in bioinformatic analysis. We appreciated the Enago (http://www.enago.jp) for the English language review.

Author information

Author notes

  1. Miao Zhonghua and Zheng Hanying contributed equally to this work.

Authors and Affiliations

  1. Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 16, 3rd section, South Renmin Road, Wuhou District, Chengdu, 610041, Sichuan, People’s Republic of China

    Zhonghua Miao, Ruyue Cheng, Jinxing Li, Xi Shen & Fang He

  2. School of Public Health, Xiamen University, Xiamen, China

    Hanying Zheng, Hui Lan & Hongwei Li

  3. Inner Mongolia Yili Industrial Group Co., Ltd, Hohhot, 010110, China

    Wei-Hsien Liu, Ting Sun, Wen Zhao, Haotian Feng & Wei-Lian Hung

Authors
  1. Zhonghua Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanying Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-Hsien Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruyue Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ting Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wen Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jinxing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xi Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hongwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Haotian Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Wei-Lian Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Fang He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei-Lian Hung or Fang He.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 495 KB)

Supplementary file2 (DOCX 15 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miao, Z., Zheng, H., Liu, WH. et al. Lacticaseibacillus paracasei K56 Attenuates High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota in Mice. Probiotics & Antimicro. Prot. 15, 844–855 (2023). https://doi.org/10.1007/s12602-022-09911-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12602-022-09911-x

Keywords

Search

Navigation